Biohaven Ltd (BHVN)

CEO:
Vladimir Coric
Employees:
215 CHURCH STREET, NEW HAVEN, CT, 06510
203-404-0410

Biohaven Ltd. is a clinical-stage biopharmaceutical company. The Company focuses on development of therapies for neurological and immunoscience diseases that can change current treatment paradigms.

Are you looking for this stock instead?

View recent insider trading info

Biohaven Ltd YCharts
Yahoo! Finance finviz

Funds Holding BHVN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BHVN

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

CLARK GEORGE C. VP, CHIEF ACCOUNTING OFFICER

  • Officer
 64,285 2022-11-08 3

CORIC VLAD CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
 2,544,614 2022-10-31 9

CHILDS JOHN W

  • Director
 5,696,251 2022-10-25 8

GREGORY JULIA P

  • Director
 25,665 2022-10-25 5

BAILEY GREGORY

  • Director
 1,507,971 2022-10-25 6

BUTEN MATTHEW CHIEF FINANCIAL OFFICER

  • Officer
 166,653 2022-10-25 4

HUGIN ROBERT J

  • Director
 12,959 2022-10-03 5

JONES WILLIAM A JR CCO-MIGRAINE & COMMON DISEASE

  • Officer
 0 2022-10-03 1

HEFFERNAN MICHAEL THOMAS

  • Director
 0 2022-10-03 5

BIOHAVEN PHARMACEUTICAL HOLDING CO LTD.

  • 10% Owner
 0 2022-10-03 2

GENTILE KIMBERLY SVP, CLINICAL OPERATIONS

  • Officer
 511,479 2022-10-03 3

TILTON JOHN CHIEF COMMERCIAL OFFICER

  • Officer
 0 2022-10-03 1

ENGELHART JAMES STRATEGIC ADVISOR

  • Officer
 0 2022-10-03 1

CONWAY CHARLES CHIEF SCIENTIFIC OFFICER

  • Officer
 0 2022-10-03 1

STOCK ELYSE CHIEF MEDICAL OFFICER

  • Officer
 0 2022-10-03 1

CAR BRUCE CHIEF SCIENTIFIC OFFICER

  • Officer
 300,000 2022-10-03 2

MEHTA KISHAN

  • Director
 0 2022-10-03 4

ANTONIJEVIC IRINA

  • Director
 127,535 2022-10-03 5

DOOGAN DECLAN

  • Director
 4,637,064 2021-12-31 0

BERMAN ROBERT SPECIAL PROJECTS & MED OVRSGHT

  • Officer
 790,891 2020-07-08 0

AGUIAR ERIC

  • Director
 1,250 2020-01-22 0

REPELLA ROBERT

  • Director
 18,000 2019-05-21 0

CHA ALBERT

  • Director
 2,067,545 2018-05-01 0

PORTAGE BIOTECH INC.

  • FORMER 10% OWNER
 No longer subject to file 2018-01-19 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
BIOHAVEN LTD BHVN 2023-03-31 22:15:04 UTC 4.2198 0.6002 250000
BIOHAVEN LTD BHVN 2023-03-31 21:45:05 UTC 4.2198 0.6002 250000
BIOHAVEN LTD BHVN 2023-03-31 21:15:03 UTC 4.2198 0.6002 250000
BIOHAVEN LTD BHVN 2023-03-31 20:45:04 UTC 4.2198 0.6002 200000
BIOHAVEN LTD BHVN 2023-03-31 20:15:04 UTC 4.2198 0.6002 200000
BIOHAVEN LTD BHVN 2023-03-31 19:45:04 UTC 4.2198 0.6002 200000
BIOHAVEN LTD BHVN 2023-03-31 19:15:04 UTC 4.2198 0.6002 200000
BIOHAVEN LTD BHVN 2023-03-31 18:45:04 UTC 4.2198 0.6002 200000
BIOHAVEN LTD BHVN 2023-03-31 18:15:04 UTC 4.2198 0.6002 200000
BIOHAVEN LTD BHVN 2023-03-31 17:45:04 UTC 4.2198 0.6002 200000
BIOHAVEN LTD BHVN 2023-03-31 17:15:03 UTC 4.2198 0.6002 200000
BIOHAVEN LTD BHVN 2023-03-31 16:45:04 UTC 4.2172 0.6028 200000
BIOHAVEN LTD BHVN 2023-03-31 16:15:04 UTC 4.2172 0.6028 250000
BIOHAVEN LTD BHVN 2023-03-31 15:45:04 UTC 4.2172 0.6028 250000
BIOHAVEN LTD BHVN 2023-03-31 15:15:03 UTC 4.2172 0.6028 250000
BIOHAVEN LTD BHVN 2023-03-31 14:45:04 UTC 4.2172 0.6028 250000
BIOHAVEN LTD BHVN 2023-03-31 14:15:04 UTC 4.2172 0.6028 300000
BIOHAVEN LTD BHVN 2023-03-31 13:45:03 UTC 4.2047 0.6153 300000
BIOHAVEN LTD BHVN 2023-03-31 13:15:03 UTC 4.2047 0.6153 300000
BIOHAVEN LTD BHVN 2023-03-31 12:45:03 UTC 4.2047 0.6153 300000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

Elevate your investments